Company Recordati OTC Markets

Equities

RCDTF

IT0003828271

Pharmaceuticals

Market Closed - OTC Markets 10:25:52 2024-01-25 am EST 5-day change 1st Jan Change
51.6 USD -0.73% Intraday chart for Recordati -.--% +12.17%

Business Summary

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (32.1%).

Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).

Number of employees: 4,455

Sales per Business

EUR in Million2022Weight2023Weight Delta
Specialty & Primary Care
65.7 %
1,258 67.9 % 1,368 65.7 % +8.75%
Rare Diseases
34.3 %
596 32.1 % 715 34.3 % +19.96%

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe
56.4 %
1,084 58.5 % 1,175 56.4 % +8.37%
America
19.0 %
324 17.5 % 395 19.0 % +22.06%
Italy
15.2 %
277 15.0 % 317 15.2 % +14.36%
Australasia
6.7 %
115 6.2 % 140 6.7 % +21.69%
Africa
2.7 %
53 2.9 % 56 2.7 % +3.96%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 21-11-30
Director of Finance/CFO 54 19-10-31
Chairman 52 98-04-28
Chief Tech/Sci/R&D Officer - 17-06-30
Director/Board Member 71 20-04-28
Investor Relations Contact 51 20-09-30
General Counsel - 23-03-31
General Counsel - 23-03-31
Human Resources Officer - 22-12-31
Corporate Officer/Principal - 07-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 51 18-06-11
Director/Board Member 55 18-06-11
Chief Executive Officer 61 21-11-30
Director/Board Member 51 22-04-28
Director/Board Member 56 20-04-28
Director of Finance/CFO 54 19-10-31
Director/Board Member 62 21-12-15
Director/Board Member 53 14-04-16
Director/Board Member 71 20-04-28
Director/Board Member 60 19-02-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,125,156 97,110,939 ( 46.44 %) 3,119,044 ( 1.491 %) 46.44 %

Shareholders

NameEquities%Valuation
CVC Advisers Ltd.
51.82 %
108,368,721 51.82 % 5 997 M $
Invesco Asset Management Ltd.
2.278 %
4,763,870 2.278 % 264 M $
RECORDATI
1.801 %
3,765,552 1.801 % 208 M $
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.6352 %
1,328,419 0.6352 % 74 M $
Invesco Advisers, Inc.
0.5980 %
1,250,568 0.5980 % 69 M $
ANIMA Sgr SpA
0.5431 %
1,135,689 0.5431 % 63 M $
Amundi Asset Management SA (Investment Management)
0.4526 %
946,561 0.4526 % 52 M $
DWS Investments Italy SGR SpA
0.4225 %
883,639 0.4225 % 49 M $
Capitalia Asset Management SGR SpA
0.4065 %
850,000 0.4065 % 47 M $
Eurizon Capital SGR SpA
0.3329 %
696,252 0.3329 % 39 M $

Holdings

NameEquities%Valuation
3,765,552 1.80% 208,382,635 $
9,554,140 3.54% 26,854,108 $
43,103 0.71% 138,723 $

Company contact information

Recordati SpA

Via Matteo Civitali, 1

20148, Milan

+39 02 487871

http://www.recordati.it/
address Recordati(RCDTF)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Drugstore Chains
Recordati Ilac San ve Tic AS
Household/Personal Care
Medical Distributors

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
50.75 EUR
Average target price
52.14 EUR
Spread / Average Target
+2.74%
Consensus